Bennicas & Associates Inc. reduced its stake in shares of Procter & Gamble Co (NYSE:PG) by 1.0% in the 4th quarter, HoldingsChannel reports. The fund owned 155,926 shares of the company’s stock after selling 1,551 shares during the period. Procter & Gamble makes up 12.5% of Bennicas & Associates Inc.’s investment portfolio, making the stock its largest position. Bennicas & Associates Inc.’s holdings in Procter & Gamble were worth $14,326,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in PG. Harding Loevner LP acquired a new stake in Procter & Gamble in the second quarter valued at approximately $119,000. Cerebellum GP LLC acquired a new stake in Procter & Gamble in the fourth quarter valued at approximately $122,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Procter & Gamble in the third quarter valued at approximately $125,000. Blume Capital Management Inc. grew its holdings in Procter & Gamble by 25.4% in the second quarter. Blume Capital Management Inc. now owns 1,482 shares of the company’s stock valued at $129,000 after purchasing an additional 300 shares during the period. Finally, James Investment Research Inc. grew its holdings in Procter & Gamble by 400.0% in the fourth quarter. James Investment Research Inc. now owns 1,500 shares of the company’s stock valued at $138,000 after purchasing an additional 1,200 shares during the period. Institutional investors own 60.98% of the company’s stock.
Several analysts have commented on the company. Jefferies Group reissued a “buy” rating and issued a $99.00 price objective on shares of Procter & Gamble in a report on Monday, December 18th. Wells Fargo reissued a “hold” rating and issued a $88.00 price objective on shares of Procter & Gamble in a report on Sunday, December 17th. Deutsche Bank assumed coverage on Procter & Gamble in a report on Tuesday, December 19th. They issued a “buy” rating and a $91.88 price objective on the stock. Zacks Investment Research raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $102.00 price objective on the stock in a report on Monday, January 8th. Finally, Goldman Sachs raised Procter & Gamble from a “sell” rating to a “neutral” rating and set a $77.00 price objective on the stock in a report on Tuesday, January 16th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $86.41.
Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Tuesday, January 23rd. The company reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.05. The firm had revenue of $17.40 billion for the quarter, compared to analyst estimates of $17.39 billion. Procter & Gamble had a return on equity of 20.66% and a net margin of 15.34%. The business’s revenue was up 3.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.08 earnings per share. research analysts anticipate that Procter & Gamble Co will post 4.18 EPS for the current fiscal year.
In other Procter & Gamble news, insider Marylynn Fergusonmchugh sold 2,353 shares of the business’s stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $78.59, for a total transaction of $184,922.27. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Deborah P. Majoras sold 4,591 shares of the business’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $87.48, for a total value of $401,620.68. The disclosure for this sale can be found here. Insiders sold 114,011 shares of company stock worth $9,710,976 over the last ninety days. Corporate insiders own 0.35% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was published by WKRB News and is the sole property of of WKRB News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.wkrb13.com/2018/04/01/bennicas-associates-inc-trims-position-in-procter-gamble-co-pg.html.
Procter & Gamble Company Profile
The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.